. 2021 May 24;44:102014. doi: 10.1016/j.redox.2021.102014

Table 3.

α, β and γ-tubulin modification sites identified in SIN-1 treated and untreated cardiac cells.

AA	#_modified	#_{modifications}	modified residues	modifications
α-tubulin
Cys	2	2	C347^c, C376^d	^cGlutathionylation, ^dNitrosation
Lys	1	1	K96^g	^gFormylation
Met	6	2	M154^a, M302^a, M377^ab, M398^a, M413^a, M425^a	^aOxidation, ^bDioxidation
Thr	1	1	T337ⁱ	ⁱPhosphorylation
β-tubulin
His	1	2	H264^ae	^aOxidation, ^eHexenal
Lys	2	2	K103^f, K252^g	^fDimethylation, ^gFormylation
Met	14	2	M1^a, M73^ab, M147^a, M164^a, M170^a, M233^a, M257^ab, M267^ab, M293^a, M321^ab, M323^ab, M330^a, M363^a, M388^a	^aOxidation, ^bDioxidation
Phe	2	1	F265^a, F389^a	^aOxidation
Pro	6	1	P70^a, P160^a, P171^a, P259^a, P268^a, P272^a	^aOxidation
Ser	1	1	S322ⁱ	ⁱPhosphorylation
Thr	2	1	T136^j, T166^j	^j2-amino-3-ketobutyric acid
Trp	2	4	W101^abkl, W344^abk	^aOxidation, ^bDioxidation, ^kKynurenine,^lOxolactone
Tyr	1	1	Y200^m	^mDopaquinone
γ-tubulin
Met	1	1	M377/8^b	^bDioxidation